Document

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended September 30, 2019

[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT

OF 1934

For the transition period from _________ to __________

COMMISSION FILE NUMBER 1-33926

TRECORA RESOURCES

(Exact name of registrant as specified in its charter)



DELAWARE	75-1256622
(State or other jurisdiction of	(I.R.S. Employer Identification No.)
incorporation or organization)



1650 Hwy 6 South, Suite 190	77478
Sugar Land, Texas	(Zip code)
(Address of principal executive offices)

Registrant's telephone number, including area code: (281) 980-5522

N/A

Former name, former address and former fiscal year, if changed since last report.

Securities registered pursuant to Section 12(b) of the Act:



Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Common Stock, par value $0.10 per share	TREC	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days. Yes X No

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S–T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes X No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of "large accelerated filer," "accelerated filer," "smaller reporting company" and "emerging growth company" in Rule 12b-2 of the Exchange Act.

Large accelerated filer Accelerated filer X

Non-accelerated filer Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.____

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes No X

Number of shares of the Registrant's Common Stock (par value $0.10 per share), outstanding at October 29, 2019: 24,714,980.

TABLE OF CONTENTS

Item Number and Description



PART I – FINANCIAL INFORMATION
ITEM 1. Financial Statements
	Condensed Consolidated Balance Sheets	1
	Condensed Consolidated Statements of Operations	2
	Condensed Consolidated Statement of Stockholders' Equity	3
	Condensed Consolidated Statements of Cash Flows	5
	Notes to Condensed Consolidated Financial Statements	6

ITEM 2. Management's Discussion and Analysis of Financial Condition and Results of Operations		22

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk		35

ITEM 4. Controls and Procedures		35
	PART II – OTHER INFORMATION
ITEM 1. Legal Proceedings		36

ITEM 1A. Risk Factors		36

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds		37

ITEM 6. Exhibits		37

PART I. FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

TRECORA RESOURCES AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS



	September 30, 2019 (Unaudited)			December 31, 2018
ASSETS	(thousands of dollars, except par value)
Current Assets
Cash	$	9,157		$	6,735
Trade receivables, net	25,497			27,112
Inventories	13,285			16,539
Investment in AMAK (held-for-sale)	34,090			38,746
Prepaid expenses and other assets	3,726			4,664
Taxes receivable	182			182
Total current assets	85,937			93,978

Plant, pipeline and equipment, net	190,345			194,657

Goodwill	21,798			21,798
Intangible assets, net	17,551			18,947
Lease right-of-use assets, net	14,364			—
Mineral properties in the United States	562			588

TOTAL ASSETS	$	330,557		$	329,968
LIABILITIES
Current Liabilities
Accounts payable	$	10,203		$	19,106
Accrued liabilities	7,270			5,439
Current portion of long-term debt	4,194			4,194
Current portion of lease liabilities	3,247			—
Current portion of other liabilities	1,011			752
Total current liabilities	25,925			29,491

Long-term debt, net of current portion	85,143			98,288
Lease liabilities, net of current portion	11,117			—
Other liabilities, net of current portion	906			1,352
Deferred income taxes	16,646			15,676
Total liabilities	139,737			144,807

EQUITY
Common stock‑authorized 40 million shares of $0.10 par value; issued and outstanding 24.7 million and 24.6 million in 2019 and 2018, respectively	2,472			2,463
Additional paid-in capital	59,202			58,294
Common stock in treasury, at cost	(2		)	(8		)
Retained earnings	128,859			124,123
Total Trecora Resources Stockholders' Equity	190,531			184,872
Noncontrolling Interest	289			289
Total equity	190,820			185,161

TOTAL LIABILITIES AND EQUITY	$	330,557		$	329,968

See notes to consolidated financial statements.



Table of Contents
	1

TRECORA RESOURCES AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)



	THREE MONTHS ENDED SEPTEMBER 30,						NINE MONTHS ENDED SEPTEMBER 30,
	2019			2018			2019			2018
	(thousands of dollars, except per share amounts)
REVENUES
Product sales	$	59,111		$	68,613		$	185,933		$	198,881
Processing fees	3,604			4,803			11,308			14,382
	62,715			73,416			197,241			213,263

OPERATING COSTS AND EXPENSES
Cost of sales and processing
(including depreciation and amortization of $3,254, $3,813, $11,611 and $9,480, respectively)	53,148			66,574			167,036			188,139

GROSS PROFIT	9,567			6,842			30,205			25,124

GENERAL AND ADMINISTRATIVE EXPENSES
General and administrative	6,401			6,327			18,532			17,216
Depreciation	208			205			629			592
	6,609			6,532			19,161			17,808

OPERATING INCOME	2,958			310			11,044			7,316

OTHER INCOME (EXPENSE)
Interest income	—			5			5			26
Interest expense	(1,211		)	(924		)	(4,111		)	(2,617		)
Loss on Extinguishment of Debt	—			(315		)	—			(315		)
Miscellaneous income (expense), net	74			(28		)	330			(67		)
	(1,137		)	(1,262		)	(3,776		)	(2,973		)

INCOME (LOSS) FROM CONTINUING OPERATIONS BEFORE INCOME TAXES	1,821			(952		)	7,268			4,343

INCOME TAX EXPENSE (BENEFIT)	238			(236		)	1,412			854

INCOME (LOSS) FROM CONTINUING OPERATIONS	1,583			(716		)	5,856			3,489

LOSS FROM DISCONTINUED OPERATIONS, NET OF TAX	(1,002		)	(893		)	(1,120		)	(531		)

NET INCOME (LOSS)	$	581		$	(1,609	)	$	4,736		$	2,958

Basic Earnings per Common Share
Net income (loss) from continuing operations (dollars)	$	0.06		$	(0.03	)	$	0.24		$	0.14
Net loss from discontinued operations, net of tax (dollars)	(0.04		)	(0.04		)	(0.05		)	(0.02		)
Net income (loss) (dollars)	$	0.02		$	(0.07	)	$	0.19		$	0.12

Basic weighted average number of common shares outstanding	24,717			24,483			24,689			24,397

Diluted Earnings per Common Share
Net income (loss) from continuing operations (dollars)	$	0.06		$	(0.03	)	$	0.23		$	0.14
Net loss from discontinued operations, net of tax (dollars)	(0.04		)	(0.04		)	(0.04		)	(0.02		)
Net income (loss) (dollars)	$	0.02		$	(0.07	)	$	0.19		$	0.12

Diluted weighted average number of common shares outstanding	25,053			25,175			25,077			25,138

See notes to consolidated financial statements.



Table of Contents
	2

TRECORA RESOURCES AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (UNAUDITED)

THREE MONTHS ENDED SEPTEMBER 30



	TRECORA RESOURCES STOCKHOLDERS
	COMMON STOCK			ADDITIONAL PAID-IN			TREASURY			RETAINED						NON- CONTROLLING		TOTAL
	SHARES	AMOUNT		CAPITAL			STOCK			EARNINGS			TOTAL			INTEREST		EQUITY
	(thousands)	(thousands of dollars)
June 30, 2019	24,715	$	2,472	$	58,920		$	(2	)	$	128,278		$	189,668		$	289	$	189,957

Restricted Stock Units
Issued to Directors	—	—		96			—			—			96			—		96
Issued to Employees	—	—		186			—			—			186			—		186
Common Stock
Issued to Directors	—	—		—			—			—			—			—		—
Issued to Employees	—	—		—			—			—			—			—		—
Net Income	—	—		—			—			581			581			—		581

September 30, 2019	24,715	$	2,472	$	59,202		$	(2	)	$	128,859		$	190,531		$	289	$	190,820

June 30, 2018	24,311	$	2,451	$	56,365		$	(61	)	$	131,022		$	189,777		$	289	$	190,066

Stock Options
Issued to Directors	—	—		—			—			—			—			—		—
Issued to Employees	—	—		—			—			—			—			—		—
Cancellation of Issuance to Former Director	—	—		—			—			—			—			—		—
Restricted Stock Units
Issued to Directors	—	—		75			—			—			75			—		75
Issued to Employees	—	—		550			—			—			550			—		550
Common Stock
Issued to Directors	—	—		159			41			—			200			—		200
Issued to Employees	—	—		(2		)	1			—			(1		)	—		(1		)
Stock Exchange	—	—		—			—			—			—			—		—
Warrants	—	—		—			—			—			—			—		—
Net Income	—	—		—			—			(1,609		)	(1,609		)	—		(1,609		)

September 30, 2018	24,311	$	2,451	$	57,147		$	(19	)	$	129,413		$	188,992		$	289	$	189,281

See notes to consolidated financial statements.



Table of Contents
	3

TRECORA RESOURCES AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (UNAUDITED)

NINE MONTHS ENDED SEPTEMBER 30



	TRECORA RESOURCES STOCKHOLDERS
	COMMON STOCK			ADDITIONAL PAID-IN			TREASURY			RETAINED					NON- CONTROLLING		TOTAL
	SHARES	AMOUNT		CAPITAL			STOCK			EARNINGS		TOTAL			INTEREST		EQUITY
	(thousands)	(thousands of dollars)
January 1, 2019	24,626	$	2,463	$	58,294		$	(8	)	$	124,123	$	184,872		$	289	$	185,161

Restricted Stock Units
Issued to Directors	—	—		264			—			—		264			—		264
Issued to Employees	—	—		644			—			—		644			—		644
Common Stock
Issued to Directors	10	1		—			6			—		7			—		7
Issued to Employees	79	8		—			—			—		8			—		8
Net Income	—	—		—			—			4,736		4,736			—		4,736

September 30, 2019	24,715	$	2,472	$	59,202		$	(2	)	$	128,859	$	190,531		$	289	$	190,820

January 1, 2018	24,311	$	2,451	$	56,012		$	(196	)	$	126,455	$	184,722		$	289	$	185,011

Stock Options
Issued to Directors	—	—		(10		)	—			—		(10		)	—		(10		)
Issued to Employees	—	—		154			—			—		154			—		154
Cancellation of Issuance to Former Director	—	—		(680		)	—			—		(680		)	—		(680		)
Restricted Stock Units
Issued to Directors	—	—		250			—			—		250			—		250
Issued to Employees	—	—		1,284			—			—		1,284			—		1,284
Common Stock
Issued to Directors	—	—		82			78			—		160			—		160
Issued to Employees	—	—		130			155			—		285			—		285
Stock Exchange	—	—		(66		)	(65		)	—		(131		)	—		(131		)
Warrants	—	—		(9		)	9			—		—			—		—
Net Income	—	—		—			—			2,958		2,958			—		2,958

September 30, 2018	24,311	$	2,451	$	57,147		$	(19	)	$	129,413	$	188,992		$	289	$	189,281

See notes to consolidated financial statements.



Table of Contents
	4

TRECORA RESOURCES AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (UNAUDITED)



	NINE MONTHS ENDED SEPTEMBER 30,
	2019			2018
	(thousands of dollars)
OPERATING ACTIVITIES
Net Income	$	4,736		$	2,958
Loss from Discontinued Operations	(1,120		)	(531		)
Income from Continuing Operations	$	5,856		$	3,489
Adjustments to Reconcile Income from Continuing Operations To Net Cash Provided by Operating Activities:
Depreciation and Amortization	10,863			8,614
Amortization of Intangible Assets	1,396			1,396
Stock-based Compensation	904			1,002
Deferred Income Taxes	1,268			1,116
Postretirement Obligation	(28		)	(817		)
Bad Debt Expense	(19		)	152
Amortization of Loan Fees	136			216
Loss on Extinguishment of Debt	—			315
Changes in Operating Assets and Liabilities:
Decrease (Increase) in Trade Receivables	1,634			(4,160		)
Increase in Insurance Receivables	—			(391		)
Decrease in Taxes Receivable	—			4,029
Decrease in Inventories	3,253			622
Increase in Prepaid Expenses and Other Assets	914			(1,592		)
Decrease in Accounts Payable and Accrued Liabilities	(6,031		)	(2,977		)
Decrease in Other Liabilities	267			96
Net Cash Provided by Operating Activities - Continuing Operations	20,413			11,110
Net Cash Used in Operating Activities - Discontinued Operations	(164		)	—
Net Cash Provided by Operating Activities	20,249			11,110
INVESTING ACTIVITIES
Additions to Plant, Pipeline and Equipment	(6,978		)	(19,090		)
Proceeds from PEVM	27			—
Net Cash Used in Investing Activities - Continuing Operations	(6,951		)	(19,090		)
Net Cash Provided by (Used in) Investing Activities - Discontinued Operations	2,697			(114		)
Net Cash Used in Investing Activities	(4,254		)	(19,204		)
FINANCING ACTIVITIES
Net Cash (Paid) Received Related to Stock-Based Compensation	(292		)	441
Additions to Long-Term Debt	2,000			18,177
Repayments of Long-Term Debt	(15,281		)	(12,260		)
Net Cash (Used in) Provided by Financing Activities - Continuing Operations	(13,573		)	6,358
NET INCREASE (DECREASE) IN CASH	2,422			(1,736		)
CASH AT BEGINNING OF PERIOD	6,735			3,028
CASH AT END OF PERIOD	$	9,157		$	1,292
Supplemental disclosure of cash flow information:
Cash payments for interest	$	3,749		$	2,663
Cash payments for taxes, net of refunds	$	53		$	209
Supplemental disclosure of non-cash items:
Capital expansion amortized to depreciation expense	$	426		$	573
Foreign taxes paid by AMAK	$	891		$	—
Stock exchange (Note 16)	$	—		$	131

See notes to consolidated financial statements.



Table of Contents
	5

TRECORA RESOURCES AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (UNAUDITED)

1. GENERAL

Organization

Trecora Resources (the "Company") was incorporated in the State of Delaware in 1967. Our principal business activities are the manufacturing of various specialty hydrocarbons and specialty waxes and the provision of custom processing services. Unless the context requires otherwise, references to "we," "us," "our," and the "Company" are intended to mean Trecora Resources and its subsidiaries.

This document includes the following abbreviations:


(1)	TREC – Trecora Resources


(2)	TOCCO – Texas Oil & Chemical Co. II, Inc. – Wholly owned subsidiary of TREC and parent of SHR and TC


(3)	SHR – South Hampton Resources, Inc. – Specialty Petrochemicals segment and parent of GSPL


(4)	GSPL – Gulf State Pipe Line Co, Inc. – Pipeline support for the Specialty Petrochemicals segment


(5)	TC – Trecora Chemical, Inc. – Specialty Waxes segment


(6)	AMAK – Al Masane Al Kobra Mining Company – Held-for-sale mining equity investment – 33% ownership


(7)	PEVM – Pioche Ely Valley Mines, Inc. – Inactive mine – 55% ownership

Basis of Presentation

The accompanying unaudited consolidated financial statements have been prepared in accordance with generally accepted accounting principles in the United States of America ("GAAP") for interim financial information and in conformity with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, these unaudited financial statements do not include all of the information and footnotes required by GAAP for complete financial statements and, therefore, should be read in conjunction with the financial statements and related notes contained in the Company's Annual Report on Form 10-K for the year ended December 31, 2018.

The unaudited condensed financial statements included in this document have been prepared on the same basis as the annual financial statements and in management's opinion reflect all adjustments, including normal recurring adjustments, necessary to present fairly the Company's financial position, results of operations and cash flows for the interim periods presented. We have made estimates and judgments affecting the amounts reported in this document. The actual results that we experience may differ materially from our estimates. In the opinion of management, the disclosures included in these financial statements are adequate to make the information presented not misleading.

Operating results for the nine months ended September 30, 2019 are not necessarily indicative of results for the year ending December 31, 2019.

We currently operate in two segments, Specialty Petrochemicals and Specialty Waxes. All revenue originates from sources in the United States, and all long-lived assets owned are located in the United States.

In addition, we own a 33% interest in AMAK, a Saudi Arabian closed joint stock company, which owns, operates and is developing mining assets in Saudi Arabia. Our investment is classified as held-for-sale and and the equity in earnings (losses) are recorded in discontinued operations. See Notes 16 and 19.

Accounting Standards Adopted in 2019

In February 2016, the Financial Accounting Standards Board ("FASB") issued ASU 2016-02, Leases (Topic 842), as amended by ASU 2017-13, 2018-01, 2018-10, 2018-11, and 2019-01, in order to increase transparency and comparability among organizations by recognizing lease assets and lease liabilities on the balance sheet for those leases classified as operating leases under prior GAAP and disclosing key information about leasing arrangements. The new standard requires that a lessee should recognize a liability to make lease payments (the lease liability) and a right-of-use asset representing its right to use the underlying asset for the lease term on the balance sheet. The Company adopted ASC 842 in the first quarter of 2019 utilizing the modified retrospective transition approach. The Company has elected (1) the package of practical expedients,



Table of Contents
	6

which permits it not to reassess under the new standard its prior conclusions about lease identification, lease classification, and initial direct costs for any existing leases as of the adoption date, and (2) the hindsight practical expedient when determining lease term and assessing impairment of right-of-use assets. In addition, the Company elected the practical expedients related to (1) certain classes of underlying asset to not separate non-lease components from lease components and (2) the short-term lease recognition exemption for all leases that qualify. The adoption of ASC 842 on January 1, 2019 resulted in the recognition of right-of-use assets of approximately $17.0 million and lease liabilities for operating leases of approximately $17.0 million on its Consolidated Balance Sheets, with no material impact to retained earnings or Consolidated Statements of Operations. See Note 8 for further information regarding the impact of the adoption of ASC 842 on the Company's consolidated financial statements.

2. RECENT ACCOUNTING PRONOUNCEMENTS

In January 2017, the FASB issued ASU No. 2017-4, Intangibles - Goodwill and Other (Topic 350). The amendments in ASU 2017-4 simplify the measurement of goodwill by eliminating Step 2 from the goodwill impairment test. Instead, under these amendments, an entity should perform its annual, or interim, goodwill impairment test by comparing the fair value of a reporting unit with its carrying amount. An entity should recognize an impairment charge for the amount by which the carrying amount exceeds the reporting unit's fair value; however, the loss should not exceed the total amount of goodwill allocated to that reporting unit. The amendments are effective for public business entities for the first interim and annual reporting periods beginning after December 15, 2019. Early adoption is permitted for interim or annual goodwill impairment tests performed on testing dates after January 1, 2017. The amendments also eliminate the requirements for any reporting unit with a zero or negative carrying amount to perform a qualitative assessment and, if it fails that qualitative test, to perform Step 2 of the goodwill impairment test. An entity still has the option to perform the qualitative assessment for a reporting unit to determine if the quantitative impairment test is necessary. The Company has goodwill from a prior business combination and performs an annual impairment test or more frequently if changes or circumstances occur that would more-likely-than-not reduce the fair value of the reporting unit below its carrying value. During the year ended December 31, 2018, the Company performed its impairment assessment and determined the fair value of the aggregated reporting units exceed the carrying value, such that the Company's goodwill was not considered impaired. Based on the most recent assessment, the Company cannot anticipate future goodwill impairment assessments. The Company does not anticipate a material impact from these amendments to the Company's financial position and results of operations. The current accounting policies and processes are not anticipated to change, except for the elimination of the Step 2 analysis.

In June 2018, the FASB issued ASU No. 2018-07, Improvements to Nonemployee Share-Based Payment Accounting. ASU 2018-07 simplifies the accounting for share-based payments to nonemployees by aligning it with the accounting for share-based payments to employees, with certain exceptions. The Company adopted this ASU on January 1, 2019 and it did not have a material effect on the Company’s consolidated financial statements.

In August 2018, the FASB issued ASU No. 2018-13, Fair Value Measurement (Topic 820) - Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement, which is designed to improve the effectiveness of disclosures by removing, modifying and adding disclosures related to fair value measurements. ASU No. 2018-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and the ASU allows for early adoption in any interim period after issuance of the update. The adoption of this ASU is not expected to have a significant impact on the Company’s consolidated financial statements.

In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments - Credit Losses (Topic 326), to require the measurement of expected credit losses for financial instruments held at the reporting date based on historical experience, current conditions and reasonable forecasts and applies to all financial assets, including trade receivables. The main objective of this ASU is to provide financial statement users with more decision-useful information about the expected credit losses on financial instruments and other commitments to extend credit held by a reporting entity at each reporting date. ASU No. 2016-13 is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, and the ASU allows for early adoption as of the beginning of an interim or annual reporting period beginning after December 15, 2018. The Company is currently assessing the impact this ASU will have on its consolidated financial statements.



Table of Contents
	7

3. TRADE RECEIVABLES

Trade receivables, net, consisted of the following:



	September 30, 2019			December 31, 2018
	(thousands of dollars)
Trade receivables	$	25,930		$	27,564
Less allowance for doubtful accounts	(433		)	(452		)
Trade receivables, net	$	25,497		$	27,112

Trade receivables serve as collateral for our amended and restated credit agreement. See Note 10.

4. PREPAID EXPENSES AND OTHER ASSETS

Prepaid expenses and other assets consisted of the following:



	September 30, 2019		December 31, 2018
	(thousands of dollars)
Prepaid license	$	1,411	$	2,419
Spare parts	1,816		1,597
Other prepaid expenses and assets	499		648
Total prepaid expenses and other assets	$	3,726	$	4,664

5. INVENTORIES

Inventories included the following:



	September 30, 2019		December 31, 2018
	(thousands of dollars)
Raw material	$	3,278	$	4,742
Work in process	157		173
Finished products	9,850		11,624
Total inventory	$	13,285	$	16,539

Inventory serves as collateral for our amended and restated credit agreement. See Note 10.

Inventory included Specialty Petrochemicals products in transit valued at approximately $3.1 million and $4.1 million at September 30, 2019, and December 31, 2018, respectively.

6. PLANT, PIPELINE AND EQUIPMENT

Plant, pipeline and equipment consisted of the following:



	September 30, 2019			December 31, 2018
	(thousands of dollars)
Platinum catalyst metal	$	1,580		$	1,612
Catalyst	4,387			3,131
Land	5,428			5,428
Plant, pipeline and equipment	259,435			253,905
Construction in progress	4,442			4,343
Total plant, pipeline and equipment	$	275,272		$	268,419
Less accumulated depreciation	(84,927		)	(73,762		)
Net plant, pipeline and equipment	$	190,345		$	194,657



Table of Contents
	8

Plant, pipeline, and equipment serve as collateral for our amended and restated credit agreement. See Note 10.

Labor capitalized for construction was approximately nil and $0.1 million for the three months and $0.1 million and $2.2 million for the nine months ended September 30, 2019 and 2018, respectively.

Construction in progress during the first nine months of 2019 included Advanced Reformer unit improvements and pipeline maintenance at SHR and equipment modifications at TC. Construction in progress during the first nine months of 2018 included equipment purchased for various equipment updates at the TC facility, the Advanced Reformer unit, tankage upgrades, and an addition to the rail spur at SHR.

Amortization relating to the catalyst, which is included in cost of sales, was approximately $0.2 million and nil for the three months and $0.7 million and nil for the nine months ended September 30, 2019 and 2018, respectively.

7. GOODWILL AND INTANGIBLE ASSETS, NET

Goodwill and intangible assets were recorded in relation to the acquisition of TC on October 1, 2014.

Goodwill was $21.8 million and $21.8 million as of September 30, 2019 and December 31, 2018, respectively.

The following tables summarize the gross carrying amounts and accumulated amortization of intangible assets by major class:



	September 30, 2019
	Gross		Accumulated Amortization			Net
Intangible assets subject to amortization (Definite-lived)	(thousands of dollars)
Customer relationships	$	16,852	$	(5,617	)	$	11,235
Non-compete agreements	94		(94		)	—
Licenses and permits	1,471		(575		)	896
Developed technology	6,131		(3,066		)	3,065
	24,548		(9,352		)	15,196
Intangible assets not subject to amortization (Indefinite-lived)
Emissions allowance	197		—			197
Trade name	2,158		—			2,158
Total	$	26,903	$	(9,352	)	$	17,551



	December 31, 2018
	Gross		Accumulated Amortization			Net
Intangible assets subject to amortization (Definite-lived)	(thousands of dollars)
Customer relationships	$	16,852	$	(4,775	)	$	12,077
Non-compete agreements	94		(80		)	14
Licenses and permits	1,471		(495		)	976
Developed technology	6,131		(2,606		)	3,525
	24,548		(7,956		)	16,592
Intangible assets not subject to amortization (Indefinite-lived)
Emissions allowance	197		—			197
Trade name	2,158		—			2,158
Total	$	26,903	$	(7,956	)	$	18,947

Amortization expense for intangible assets included in cost of sales for the three months ended September 30, 2019 and 2018, was approximately $0.5 million and $0.5 million, respectively, and for the nine months ended September 30, 2019 and 2018, was approximately $1.4 million and $1.4 million, respectively.



Table of Contents
	9

Based on identified intangible assets that are subject to amortization as of September 30, 2019, we expect future amortization expenses for each period to be as follows:



	Total		Remainder of 2019		2020		2021		2022		2023		2024		Thereafter
	(thousands of dollars)
Customer relationships	$	11,235	$	281	$	1,123	$	1,123	1,123		1,123		1,123		$	5,339
Licenses and permits	896		26		106		101		86		86		86		405
Developed technology	3,065		153		613		613		613		613		460		—
Total future amortization expense	$	15,196	$	460	$	1,842	$	1,837	$	1,822	$	1,822	$	1,669	$	5,744

8. LEASES

The Company leases certain rail cars, rail equipment, office space and office equipment. The Company determines if a contract is a lease at the inception of the arrangement. The Company reviews all options to extend, terminate, or purchase its right-of-use assets at the inception of the lease and accounts for these options when they are reasonably certain of being exercised.

Leases with an initial term of 12 months or less are not recorded on the consolidated balance sheets. Lease expense for these leases is recognized on a straight-line basis over the lease term.

The components of lease expense were as follows:



($ in thousands)	Classification in the Condensed Consolidated Statements of Income	Three Months Ended September 30, 2019		Nine Months Ended September 30, 2019
Operating lease cost (a)	Cost of sales, exclusive of depreciation and amortization	$	1,114	$	3,369
Operating lease cost (a)	Selling, general and administrative	34		103
Total operating lease cost		$	1,148	$	3,472

Finance lease cost:
Amortization of right-of-use assets	Depreciation	$	—	—
Interest on lease liabilities	Interest Expense	—		—
Total finance lease cost		$	—	$	—

Total lease cost		$	1,148	$	3,472

(a) Short-term lease costs were approximately $64 thousand during the period.



Table of Contents
	10

The Company had no variable lease expense, as defined by ASC 842, during the period.



($ in thousands)	Classification on the Condensed Consolidated Balance Sheets	September 30, 2019
Assets:
Operating	Operating lease assets	$	14,364
Finance	Property, plant, and equipment	—
Total leased assets		$	14,364

Liabilities:
Current
Operating	Current portion of operating lease liabilities	$	3,247
Finance	Short-term debt and current portion of long-term debt	—
Noncurrent
Operating	Operating lease liabilities	11,117
Finance	Long-term debt	—
Total lease liabilities		$	14,364



($ in thousands)	Three Months Ended September 30, 2019		Nine Months Ended September 30, 2019
Cash paid for amounts included in the measurement of lease liabilities:
Operating cash flows used for operating leases	$	1,127	$	2,260
Operating cash flows used for finance leases	—		—
Financing cash flows used for finance leases	—		—
Right-of-use assets obtained in exchange for lease obligations:
Operating leases	$	25	$	138
Finance leases	—		—



	September 30, 2019
Weighted-average remaining lease term (in years):
Operating leases	4.8
Finance leases	0.0
Weighted-average discount rate:
Operating leases	4.5	%
Finance leases	—	%

Nearly all of the Company’s lease contracts do not provide a readily determinable implicit rate. For these contracts, the Company’s estimated incremental borrowing rate is based on information available at the inception of the lease.

As of September 30, 2019, maturities of lease liabilities were as follows:



($ in thousands)	Operating Leases		Finance Leases
2020	$	3,811	$	—
2021	3,559		—
2022	3,391		—
2023	2,571		—
2024	1,243		—
Thereafter	1,329		—
Total lease payments	$	15,904	$	—
Less: Interest	1,540		—
Total lease obligations	$	14,364	$	—



Table of Contents
	11

Disclosures related to periods prior to adoption of ASU 2016-02

The Company adopted ASU 2016-02 using a modified retrospective transition approach on January 1, 2019 as noted in Note 1. As required, the following disclosure is provided for periods prior to adoption. Minimum lease commitments as of December 31, 2018 that have initial or remaining lease terms in excess of one year are as follows:



($ in thousands)	Operating Leases
2019	$	3,670
2020	3,583
2021	3,418
2022	3,107
2023	2,288
Beyond 2023	2,065

9. ACCRUED LIABILITIES

Accrued liabilities consisted of the following:



	September 30, 2019		December 31, 2018
	(thousands of dollars)
Accrued state taxes	249		210
Accrued property taxes	2,572		—
Accrued payroll	812		936
Accrued interest	32		31
Accrued officer compensation	1,251		—
Accrued restructuring & severance	37		1,221
Accrued foreign taxes	—		802
Other	2,317		2,239
Total	$	7,270	$	5,439

10. LIABILITIES AND LONG-TERM DEBT

Senior Secured Credit Facilities

As of September 30, 2019, we had $8.0 million in borrowings outstanding under the revolving credit facility (the "Revolving Facility") of our amended and restated credit agreement (as amended to the date hereof, the "ARC Agreement") and approximately $82.0 million in borrowings outstanding under the term loan facility of the ARC Agreement (the "Term Loan Facility" and, together with the Revolving Facility, the "Credit Facilities"). In addition, we had approximately $46 million of availability under our Revolving Facility at September 30, 2019. TOCCO’s ability to make additional borrowings under the Revolving Facility at September 30, 2019 was limited by, and in the future may be limited by our obligation to maintain compliance with the covenants contained in the ARC Agreement (including maintenance of a maximum Consolidated Leverage Ratio and minimum Consolidated Fixed Charge Coverage Ratio (each as defined in the ARC Agreement)).

On March 29, 2019, TOCCO, as borrower, and SHR, GSPL and TC, as guarantors, entered into a Sixth Amendment (“Sixth Amendment”) to the ARC Agreement. Pursuant to the Sixth Amendment, certain amendments were made to the terms of the ARC Agreement, including increasing the maximum Consolidated Leverage Ratio that must be maintained by TOCCO to 4.75 to 1.00 for the four fiscal quarters ended March 31, 2019, 4.50 to 1.00 for the four fiscal quarters ended June 30, 2019 and 4.00 to 1.00 for the four fiscal quarters ended September 30, 2019. For the four fiscal quarters ended December 31, 2019 and each fiscal quarter thereafter, TOCCO must maintain a Consolidated Leverage Ratio of 3.50 to 1.00 (subject to temporary increase following certain acquisitions).

The maturity date for the ARC Agreement is July 31, 2023. As of September 30, 2019, the effective interest rate for the Credit Facilities was 4.59%. The ARC Agreement contains a number of customary affirmative and negative covenants and we were in compliance with those covenants as of September 30, 2019.



Table of Contents
	12

For a summary of additional terms of the Credit Facilities, see Note 12, “Long-Term Debt and Long-Term Obligations” to the consolidated financial statements set forth in our Annual Report on Form 10-K for the year ended December 31, 2018.

Debt Issuance Costs

Debt issuance costs of approximately $0.9 million were incurred in connection with the fourth amendment to the ARC Agreement. Unamortized debt issuance costs of approximately $0.7 million and $0.8 million for the periods ended September 30, 2019 and December 31, 2018, have been netted against outstanding loan balances.

Long-term debt and long-term obligations are summarized as follows:



	September 30, 2019		December 31, 2018
	(thousands of dollars)
Revolving Facility	8,000		18,000
Term Loan Facility	82,031		85,312
Loan fees	(694	)	(830	)
Total long-term debt	89,337		102,482

Less current portion including loan fees	4,194		4,194

Total long-term debt, less current portion including loan fees	85,143		98,288

Subsequent to September 30, 2019, we made an optional principal payment of $5.0 million against the Revolving Facility, reducing the outstanding amount from $8.0 million to $3.0 million.

11. STOCK-BASED COMPENSATION

The Stock Option Plan for Key Employees, as well as, the Non-Employee Director Stock Option Plan (hereinafter collectively referred to as the “Stock Option Plans”), were approved by the Company’s stockholders in July 2008. The Stock Option Plans allot for the issuance of up to 1,000,000 shares.

The Trecora Resources Stock and Incentive Plan (the “Plan”) was approved by the Company’s stockholders in June 2012. As amended, the Plan allots for the issuance of up to 2.5 million shares in the form of stock options or restricted stock unit awards.

Stock-based compensation expense of approximately $0.3 million and $0.6 million was recognized during the three months and $0.9 million and $1.0 million for the nine months ended September 30, 2019 and 2018, respectively.

Stock Options and Warrant Awards

Stock options and warrants granted under the provisions of the Stock Option Plans permit the purchase of our common stock at exercise prices equal to the closing price of Company common stock on the date the options were granted. The options have terms of 10 years and generally vest ratably over terms of 4 to 5 years. There were no stock options or warrant awards issued during the three or nine months ended September 30, 2019 or 2018.



Table of Contents
	13

A summary of the status of the Company’s stock option and warrant awards is as follows:



	Stock Options and Warrants		Weighted Average Exercise Price Per Share	Weighted Average Remaining Contractual Life	Intrinsic Value (in thousands)
Outstanding at January 1, 2019	745,830		10.33
Granted	—		—
Exercised	(85,000	)	7.71
Forfeited	(173,830	)	10.10
Outstanding at September 30, 2019	487,000		10.87	3.8	$	—
Expected to vest	—				$	—
Exercisable at September 30, 2019	487,000		10.87	3.8	$	—

The aggregate intrinsic value of options was calculated as the difference between the exercise price of the underlying awards and the quoted price of our common stock. At September 30, 2019, options to purchase approximately 0.1 million shares of common stock were in-the-money.

Since no options were granted, the weighted average grant-date fair value per share of options granted during the three months ended September 30, 2019 and 2018, respectively, was $0. During the nine months ended September 30, 2019 and 2018, the aggregate intrinsic value of options and warrants exercised was approximately $0.1 million and $0.6 million, respectively, determined as of the date of option exercise.

The Company received no cash from the exercise of options during the nine months ended September 30, 2019 and 2018. Of the 85,000 stock options exercised, the Company only issued approximately 11,000 shares due to cashless transactions. The tax benefit realized from the exercise was insignificant.

The Company has no non-vested options as of September 30, 2019.

Restricted Stock Unit Awards

Generally, restricted stock unit awards are granted annually to officers and directors of the Company under the provisions of the Plan. Restricted stock units are also granted ad hoc to attract or retain key personnel, and the terms and conditions under which these restricted stock units vest vary by award. The fair market value of restricted stock units granted is equal to the Company’s closing stock price on the date of grant. Restricted stock units granted generally vest ratably over periods ranging from 2.5 to 5 years. Certain awards also include vesting provisions based on performance metrics. Upon vesting, the restricted stock units are settled by issuing one share of Company common stock per unit.

A summary of the status of the Company's restricted stock units activity is as follows:



	Shares of Restricted Stock Units		Weighted Average Grant Date Price per Share
Outstanding at January 1, 2019	405,675		11.27
Granted	190,615		9.22
Forfeited	(123,434	)	10.82
Vested	(136,568	)	11.86
Outstanding at September 30, 2019	336,288		9.83
Expected to vest	336,288

12. INCOME TAXES

We file an income tax return in the U.S. federal jurisdiction and a margin tax return in Texas. We received notification from the Internal Revenue Service ("IRS") in November 2016 that the December 31, 2014, tax return was selected for audit. In April 2017, the audit was expanded to include the year ended December 31, 2015, to review the refund claim related to



Table of Contents
	14

research and development activities. We received notification from the IRS in March 2018 that the audit was complete. We also received notification that Texas will audit our R&D credit calculations for 2014 and 2015. We were notified by Texas that the audit has been temporarily suspended as the Comptroller's office reviews its audit process regarding R&D credits. We do not expect any changes related to the Texas audit. Tax returns for various jurisdictions remain open for examination for the years 2014 through 2018. As of September 30, 2019 and December 31, 2018, respectively, we recognized no adjustment for uncertain tax positions or related interest and penalties.

The effective tax rate varies from the federal statutory rate of 21%, primarily as a result of state tax expense, stock based compensation and a research and development credit for the three and nine months ended September 30, 2019 and 2018. We continue to maintain a valuation allowance against certain deferred tax assets, specifically for mining claims for PEVM, where realization is not certain.

13. NET INCOME PER COMMON SHARE

The following tables set forth the computation of basic and diluted net income (loss) per share for the three and nine months ended September 30, 2019 and 2018, respectively.

Net Income per Common Share - Continuing Operations



	Three Months Ended September 30, 2019					Three Months Ended September 30, 2018
	Income (Loss)		Shares	Per Share Amount		Income (Loss)			Shares	Per Share Amount
	(in thousands, except per share amounts)
Basic:
Net income (loss) from continuing operations	$	1,583	24,717	$	0.06	$	(716	)	24,483	$	(0.03	)
Unvested restricted stock units			336						398
Dilutive stock options outstanding			—						294
Diluted:
Net income (loss) from continuing operations	$	1,583	25,053	$	0.06	$	(716	)	25,175	$	(0.03	)



	Nine Months Ended September 30, 2019					Nine Months Ended September 30, 2018
	Income		Shares	Per Share Amount		Income		Shares	Per Share Amount
	(in thousands, except per share amounts)
Basic:
Net income (loss) from continuing operations	$	5,856	24,689	$	0.24	$	3,489	24,397	$	0.14
Unvested restricted stock units			388					383
Dilutive stock options outstanding			—					358
Diluted:
Net income (loss) from continuing operations	$	5,856	25,077	$	0.23	$	3,489	25,138	$	0.14



Table of Contents
	15

Net Income Common Share - Discontinued Operations



	Three Months Ended September 30, 2019							Three Months Ended September 30, 2018
	Income (Loss)			Shares	Per Share Amount			Income (Loss)			Shares	Per Share Amount
	(in thousands, except per share amounts)
Basic:
Net income (loss) from discontinued operations, net of tax	$	(1,002	)	24,717	$	(0.04	)	$	(893	)	24,483	$	(0.04	)
Unvested restricted stock units				336							398
Dilutive stock options outstanding				—							294
Diluted:
Net income (loss) from discontinued operations, net of tax	$	(1,002	)	25,053	$	(0.04	)	$	(893	)	25,175	$	(0.04	)



	Nine Months Ended September 30, 2019							Nine Months Ended September 30, 2018
	Income (Loss)			Shares	Per Share Amount			Income (Loss)			Shares	Per Share Amount
	(in thousands, except per share amounts)
Basic:
Net income (loss) from discontinued operations, net of tax	$	(1,120	)	24,689	$	(0.05	)	$	(531	)	24,397	$	(0.02	)
Unvested restricted stock units				388							383
Dilutive stock options outstanding				—							358
Diluted:
Net income (loss) from discontinued operations, net of tax	$	(1,120	)	25,077	$	(0.04	)	$	(531	)	25,138	$	(0.02	)

Net Income per Common Share



	Three Months Ended September 30, 2019					Three Months Ended September 30, 2018
	Income (Loss)		Shares	Per Share Amount		Income (Loss)			Shares	Per Share Amount
	(in thousands, except per share amounts)
Basic:
Net income (loss)	$	581	24,717	$	0.02	$	(1,609	)	24,483	$	(0.07	)
Unvested restricted stock units			336						398
Dilutive stock options outstanding			—						294
Diluted:
Net income (loss)	$	581	25,053	$	0.02	$	(1,609	)	25,175	$	(0.07	)



Table of Contents
	16



	Nine Months Ended September 30, 2019					Nine Months Ended September 30, 2018
	Income		Shares	Per Share Amount		Income		Shares	Per Share Amount
	(in thousands, except per share amounts)
Basic:
Net income (loss)	$	4,736	24,689	$	0.19	$	2,958	24,397	$	0.12
Unvested restricted stock units			388					383
Dilutive stock options outstanding			—					358
Diluted:
Net income (loss)	$	4,736	25,077	$	0.19	$	2,958	25,138	$	0.12

At September 30, 2019 and 2018, 487,000 and 873,708 shares of common stock, respectively, were issuable upon the exercise of options and warrants.

14. SEGMENT INFORMATION

We operate through business segments according to the nature and economic characteristics of our products as well as the manner in which the information is used internally by our key decision maker, who is our Chief Executive Officer. Segment data may include rounding differences.

Our Specialty Petrochemicals segment includes SHR and GSPL. Our Specialty Waxes segment is TC. We also separately identify our corporate overhead which includes administrative activities such as legal, accounting, consulting, investor relations, officer and director compensation, corporate insurance, and other administrative costs.



	Three Months Ended September 30, 2019
	Specialty Petrochemicals		Specialty Waxes			Corporate			Eliminations		Consolidated
	(in thousands)
Product sales	$	53,277	$	5,834		$	—		$	—	$	59,111
Processing fees	1,208		2,396			—			—		3,604
Total revenues	54,485		8,230			—			—		62,715
Operating profit (loss) before depreciation and amortization	10,414		(260		)	(2,670		)	—		7,484
Operating profit (loss)	7,449		(1,808		)	(2,683		)	—		2,958
Profit (loss) from continuing operations before taxes	6,583		(2,071		)	(2,691		)	—		1,821
Depreciation and amortization	1,900		1,548			14			—		3,462
Capital expenditures	2,163		361			—			—		2,524



Table of Contents
	17



	Three Months Ended September 30, 2018
	Specialty Petrochemicals		Specialty Waxes			Corporate			Eliminations		Consolidated
	(in thousands)
Product sales	$	61,675	$	6,938		$	—		—		$	68,613
Processing fees	2,056		2,799			—			(52	)	4,803
Total revenues	63,731		9,737			—			(52	)	73,416
Operating profit (loss) before depreciation and amortization	6,167		415			(2,252		)	—		4,330
Operating profit (loss)	3,516		(936		)	(2,270		)	—		310
Profit (loss) from continuing operations before taxes	2,561		(1,239		)	(2,274		)	—		(952		)
Depreciation and amortization	2,651		1,351			16			—		4,018
Capital expenditures	2,562		1,094			—			—		3,656



	Nine Months Ended September 30, 2019
	Specialty Petrochemicals		Specialty Waxes			Corporate			Eliminations		Consolidated
	(in thousands)
Product sales	$	167,351	$	18,582		$	—		$	—	$	185,933
Processing fees	4,117		7,191			—			—		11,308
Total revenues	171,468		25,773			—			—		197,241
Operating profit (loss) before depreciation and amortization	31,849		(343		)	(7,158		)	—		24,348
Operating profit (loss)	22,885		(4,638		)	(7,203		)	—		11,044
Profit (loss) from continuing operations before taxes	20,093		(5,623		)	(7,202		)	—		7,268
Depreciation and amortization	7,899		4,295			46			—		12,240
Capital expenditures	5,002		1,296			—			—		6,298



	Nine Months Ended September 30, 2018
	Specialty Petrochemicals		Specialty Waxes			Corporate			Eliminations		Consolidated
	(in thousands)
Product sales	$	178,094	$	20,755		$	—		32		$	198,881
Processing fees	5,769		8,863			—			(250	)	14,382
Total revenues	183,863		29,618			—			(218	)	213,263
Operating profit (loss) before depreciation and amortization	20,655		1,969			(5,234		)	—		17,390
Operating profit (loss)	14,635		(2,051		)	(5,268		)	—		7,316
Profit (loss) from continuing operations before taxes	12,474		(2,926		)	(5,205		)	—		4,343
Depreciation and amortization	6,020		4,020			32			—		10,072
Capital expenditures	16,374		2,716			—			—		19,090



Table of Contents
	18



	September 30, 2019
	Specialty Petrochemicals		Specialty Waxes		Corporate		Eliminations			Consolidated
	(in thousands)
Trade receivables, product sales	$	19,129	$	4,081	$	—	$	—		$	23,210
Trade receivables, processing fees	517		1,770		—		—			2,287
Goodwill and intangible assets, net	—		39,349		—		—			39,349
Total assets	293,098		113,007		90,174		(165,722		)	330,557



	December 31, 2018
	Specialty Petrochemicals		Specialty Waxes		Corporate		Eliminations			Consolidated
	(in thousands)
Trade receivables, product sales	$	21,915	$	3,173	$	—	$	—		$	25,088
Trade receivables, processing fees	633		1,391		—		—			2,024
Goodwill and intangible assets, net	—		40,745		—		—			40,745
Total assets	284,367		115,366		91,474		(161,239		)	329,968

15. POST-RETIREMENT OBLIGATIONS

We currently have post-retirement obligations with two former executives. As of September 30, 2019 and December 31, 2018, approximately $0.3 million and $0.4 million, respectively, remained outstanding and was included in post-retirement obligations.

For additional information, see Note 22, “Post–Retirement Obligations” to the consolidated financial statements set forth in our Annual Report on Form 10–K for the year ended December 31, 2018.

16. INVESTMENT IN AMAK (Held-for-Sale)

As of September 30, 2019 and December 31, 2018, the Company had a non-controlling equity interest of 33.3% and 33.4% in AMAK of approximately $34.1 million and $38.7 million, respectively. This investment is accounted for under the equity method. There were no events or changes in circumstances that may have an adverse effect on the fair value of our investment in AMAK at September 30, 2019.

The Company committed to a plan to sell our investment in AMAK during the third quarter of 2019. Management engaged in an active program to market the investment which resulted in an agreement with certain AMAK shareholders in September 2019, which became effective subsequent to September 30, 2019. See discussion of the Share Sale and Purchase Agreement in Note 19.

As all the required criteria for held-for-sale classification was met at September 30, 2019, the investment in AMAK is classified as held-for-sale in the Consolidated Balance Sheets and reflected as discontinued operations in the Consolidated Statements of Operations for all periods presented. The assets held-for-sale are disclosed by the Company in the Corporate segment. The Company expects to have no continuing involvement with the discontinued operations after the closing date. The gain (loss) from discontinued operations, net of tax, include our portion of the equity in earnings (losses) in AMAK as well as other administrative expenses incurred in Saudi Arabia and transaction costs.

AMAK's financial statements were prepared in the functional currency of AMAK which is the Saudi Riyal ("SR"). In June 1986 the SR was officially pegged to the U. S. Dollar ("USD") at a fixed exchange rate of 1 USD to 3.75 SR.



Table of Contents
	19

The summarized results of operation and financial position for AMAK are as follows:

Results of Operations



	Three Months Ended September 30,						Nine Months Ended September 30,
	2019			2018			2019			2018
	(thousands of dollars)						(thousands of dollars)
Sales	$	19,643		$	19,877		$	60,873		$	53,458
Cost of sales	19,072			20,350			55,804			49,411
Gross profit (loss)	571			(473		)	5,069			4,047
Selling, general, and administrative	3,557			2,736			9,102			7,151
Operating loss	(2,986		)	(3,209		)	(4,033		)	(3,104		)
Other income	43			35			396			70
Finance and interest expense	(456		)	(416		)	(1,349		)	(1,201		)
Loss before Zakat and income taxes	(3,399		)	(3,590		)	(4,986		)	(4,235		)
Zakat and income taxes	444			800			1,332			800
Net Loss	$	(3,843	)	$	(4,390	)	$	(6,318	)	$	(5,035	)

Financial Position



	September 30,		December 31,
	2019		2018
	(thousands of dollars)
Current assets	$	41,030	$	44,093
Noncurrent assets	191,043		212,291
Total assets	$	232,073	$	256,384

Current liabilities	$	22,107	$	17,160
Long term liabilities	74,371		77,366
Stockholders' equity	135,595		161,858
	$	232,073	$	256,384

Changes in Ownership


•	In the second quarter of 2019, certain shareholders of AMAK transferred a portion of their shares to the CEO of AMAK as a one-time retention and performance bonus. The Company transferred 100,000 shares and the transaction reduced our ownership percentage from 33.4% to 33.3%.


•	In first quarter 2018, we completed an exchange of shares with certain stockholders whereby such stockholders traded 65,000 common shares of TREC in exchange for 24,489 shares of our AMAK stock. The 65,000 shares were accounted for as treasury stock. This transaction reduced our ownership percentage from 33.44% to 33.41%.

•

In connection with the 2018 AMAK share repurchase program, we received net proceeds of approximately $0.4 million during the three months ended March 31, 2019. AMAK completed the share repurchase program in 2019, at which point all shares repurchased from AMAK stockholders were registered as treasury shares. Upon completion of the share repurchase program, the Company's ownership percentage in AMAK did not change from 33.4%.



Table of Contents
	20

The equity in the (losses) earnings of AMAK included in loss from discontinued operations, net of tax, on the consolidated statements of operations for the three and nine months ended September 30, 2019, and 2018, is comprised of the following:



	Three Months Ended September 30,						Nine Months Ended September 30,
	2019			2018			2019			2018
	(thousands of dollars)						(thousands of dollars)
AMAK Net Loss	$	(3,843	)	$	(4,390	)	$	(6,318	)	$	(5,036	)
Percentage of Ownership	33.29		%	33.41		%	33.29		%	33.41		%

Company's share of loss reported by AMAK	$	(1,279	)	$	(1,467	)	$	(2,103	)	$	(1,682	)
Amortization of difference between Company's investment in AMAK and Company's share of net assets of AMAK	337			337			1,010			1,010
Equity in (losses) earnings of AMAK	$	(942	)	$	(1,130	)	$	(1,093	)	$	(672	)

For additional information, see Note 10, "Investment in Al Masane Al Kobra Mining Company ("AMAK")" to the consolidated financial statements set forth in our Annual Report on Form 10–K for the year ended December 31, 2018.

17. RELATED PARTY TRANSACTIONS

Consulting fees of approximately $32,000 and $25,000 were incurred during the three months and $82,000 and $75,000 during the nine months ended September 30, 2019 and 2018, respectively, from our Director, Nicholas Carter. Due to his history and experience with the Company and to provide continuity after his retirement, a three year consulting agreement was entered into with Mr. Carter in July 2015. In March 2019, a new consulting agreement was entered into with Mr. Carter effective through December 31, 2019.

18. COMMITMENTS AND CONTINGENCIES

Guarantees

On October 24, 2010, we executed a limited guarantee in favor of the Saudi Industrial Development Fund ("SIDF") whereby we agreed to guaranty up to 41% of the SIDF loan (the "Loan") to AMAK in the principal amount of 330.0 million Saudi Riyals (US$88.0 million). The term of the Loan was originally through June 2019. As a condition of the Loan, SIDF required all stockholders of AMAK to execute personal or corporate guarantees; as a result, our guarantee is for approximately 135.3 million Saudi Riyals (US$36.1 million). The Loan was necessary to continue construction of the AMAK facilities and provide working capital needs. We received no consideration in connection with extending the guarantee and did so to maintain and enhance the value of our investment. On July 8, 2018, the Loan was amended to adjust the repayment schedule and extend the repayment terms through April 2024. Under the new payment terms the current amount due in 2019 is 30.0 million Saudi Riyals (US$8.0 million). The total amount outstanding on the Loan at September 30, 2019, was 290.0 million Saudi Riyals (US$77.3 million). See additional discussion including the release of the guarantee in connection with the AMAK sale in Note 19.

Operating Lease Commitments

See Note 8 for discussion on lease commitments.

Litigation

The Company is periodically named in legal actions arising from normal business activities. We evaluate the merits of these actions and, if we determine that an unfavorable outcome is probable and can be reasonably estimated, we will establish the necessary reserves. We are not currently involved in legal proceedings that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition or results of operations. We may become involved in material legal proceedings in the future.



Table of Contents
	21

Supplier Agreements

From time to time, we may incur shortfall fees due to feedstock purchases being below the minimum amounts prescribed by our agreements with our suppliers. Shortfall fee expenses for the three months ended September 30, 2019, and 2018, were $0.3 million and $0.2 million, respectively, and for the nine months ended September 30, 2019, and 2018, were $0.3 million and $0.7 million, respectively.

Environmental Remediation

Amounts charged to expense for various activities related to environmental monitoring, compliance, and improvements were approximately $0.2 million and $0.1 million for the three months ended September 30, 2019, and 2018 and for the nine months ended September 30, 2019, and 2018, were $0.7 million and $0.4 million, respectively.

19. SUBSEQUENT EVENTS

Pursuant to a Share Sale and Purchase Agreement (the “Purchase Agreement”) that was effective as of October 2, 2019, the Company has agreed to sell its entire 33.3% equity interest in AMAK, to AMAK and certain other existing shareholders of AMAK (collectively, the “Purchasers”) for an aggregate gross purchase price (before taxes and transaction expenses) of SAR 264.7 million (or approximately US$70 million), which will be payable in US Dollars. The Purchasers have advanced 5% of the purchase price (or approximately $3.5 million) in the form of a non-refundable deposit, which was a condition to the effectiveness of the Purchase Agreement. As of September 30, 2019, deposits of approximately $2.2 million were received and recorded as a reduction in our investment in AMAK. The remainder of the deposits (approximately $1.3 million) were received subsequent to September 30, 2019.

The Purchase Agreement contains various representations, warranties and indemnity obligations of the Company and the Purchasers, including the release of the Company's guarantee as described in Note 18. The Purchase Agreement also contains certain termination rights of the Company, including if closing does not occur by November 25, 2019. The transaction is expected to close in the fourth quarter of 2019, subject to receipt of certain governmental approvals and other customary closing conditions.

On October 29, 2019 the Company experienced a severe weather event at the Specialty Petrochemicals facility in Silsbee, Texas, resulting in a plant shutdown and significant damage to one of the feedstock tanks. The plant returned to operation November 7, 2019. The Company is determining the financial impact of recovery costs and expects some loss of sales volumes.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

FORWARD LOOKING AND CAUTIONARY STATEMENTS

Some of the statements and information contained in this Quarterly Report on Form 10-Q may constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Statements regarding the Company's financial position, business strategy and plans and objectives of the Company's management for future operations and other statements that are not historical facts, are forward-looking statements. Forward-looking statements are often characterized by the use of words such as "outlook," "may," "will," "should," "could," "expects," "plans," "anticipates," "contemplates," "proposes," "believes," "estimates," "predicts," "projects," "potential," "continue," "intend," or the negative of such terms and other comparable terminology, or by discussions of strategy, plans or intentions.

Forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from those expressed or implied by such statements. Such risks, uncertainties and factors include, but are not limited to: general economic conditions domestically and internationally; insufficient cash flows from operating activities; difficulties in obtaining financing; outstanding debt and other financial and legal obligations; lawsuits; competition; industry cycles; feedstock, product and mineral prices; feedstock availability; technological developments; regulatory changes; environmental matters; foreign government instability; foreign legal and political concepts; foreign currency fluctuations; not completing, or not completely realizing the anticipated benefits from, the sale of our equity interest in AMAK; receipt and timing of necessary governmental approvals for the sale of our equity interest in AMAK; and other risks detailed in this report, in our latest Annual Report on Form 10–K, including but not limited to Part I, Item 1A. Risk Factors and Part II, Item 7. Management’s Discussion and Analysis of Financial Condition and Results of Operations therein, and in our other filings with the SEC.



Table of Contents
	22

There may be other factors of which we are currently unaware or deem immaterial that may cause our actual results to differ materially from the forward-looking statements. In addition, to the extent any inconsistency or conflict exists between the information included in this report and the information included in our prior reports and other filings with the SEC, the information contained in this report updates and supersedes such information.

Forward-looking statements are based on current plans, estimates, assumptions and projections, and, therefore, you should not place undue reliance on them. Forward-looking statements speak only as of the date they are made, and we undertake no obligation to update them in light of new information or future events.

Overview

The following discussion and analysis of our financial results, as well as the accompanying unaudited consolidated financial statements and related notes to consolidated financial statements to which they refer, are the responsibility of our management. Our accounting and financial reporting fairly reflect our business model which is based on the manufacturing and marketing of specialty petrochemical products and waxes and providing custom manufacturing services.

The discussion and analysis of financial condition and the results of operations which appears below should be read in conjunction with the Management's Discussion and Analysis of Financial Condition and Results of Operations and the consolidated financial statements which appear in our Annual Report on Form 10-K for the year ended December 31, 2018.

Our preferred supplier position into the specialty petrochemicals market is derived from the combination of our reputation as a reliable supplier established over many years, the very high purity of our products, and a focused approach to customer service. In specialty waxes, we are able to deliver to our customers a performance and price point that is unique to our market; while the diversity of our custom processing assets and capabilities offers solutions to our customers that we believe are uncommon along the U.S. Gulf Coast.

Enabling our success in these businesses is a commitment to operational excellence which establishes a culture that prioritizes the safety of our employees and communities in which we operate, the integrity of our assets and regulatory compliance. This commitment drives a change to an emphasis on forward-looking, leading-indicators of our results and proactive steps to continuously improve our performance. We bring the same commitment to excellence to our commercial activities where we focus on the value proposition to our customers while understanding opportunities to maximize our value capture through service and product differentiation, supply chain and operating cost efficiencies and diversified supply options. We believe over time our focus on execution, meeting the needs of our customers and the prudent control of our costs will create value for our stockholders.

Review of Third Quarter 2019 Results

We reported third quarter 2019 net income of $0.6 million, up from net loss of $1.6 million in the third quarter of 2018. Diluted earnings per share are $0.02 for 2019, up from a loss per share of $(0.06) in 2018. Sales volume of our Specialty Petrochemicals products decreased 4.8%, and sales revenue from our Specialty Petrochemicals products decreased 13.6% as compared to the third quarter 2018. Specialty Petrochemical sales volume declined due to lower Prime product sales which declined 3.0% compared to third quarter 2018. Specialty Waxes sales revenue was down 15.9% compared to the third quarter 2018.

Consolidated Adjusted EBITDA from continuing operations was $4.9 million, for the third quarter of 2019, compared with consolidated Adjusted EBITDA from continuing operations of $3.1 million, in the third quarter of 2018. Consolidated Adjusted EBITDA from continuing operations increased due to substantially better performance in our Specialty Petrochemicals segment as a result of lower feedstock costs, lower operating expenses and improved plant operations. This was partially offset by weaker performance in our Specialty Waxes business.

Non-GAAP Financial Measures

We include in this Quarterly Report on Form 10-Q the non-GAAP financial measures of EBITDA from continuing operations and Adjusted EBITDA from continuing operations and provide reconciliations from our most directly comparable GAAP financial measures to those measures.

We believe these financial measures provide users of our financial statements with supplemental information that may be useful in evaluating our operating performance. We also believe that such non-GAAP measures, when read in conjunction



Table of Contents
	23

with our operating results presented under GAAP, can be used to better assess our performance from period to period and relative to performance of other companies in our industry, without regard to financing methods, historical cost basis or capital structure. These measures are not measures of financial performance or liquidity under GAAP and should be considered in addition to, and not as a substitute for, analysis of our results under GAAP.

EBITDA from continuing operations and Adjusted EBITDA from continuing operations: We define EBITDA from continuing operations as net income from continuing operations plus interest expense, income taxes, depreciation and amortization. We define Adjusted EBITDA from continuing operations as EBITDA from continuing operations plus stock-based compensation, plus restructuring and severance expenses, plus losses on extinguishment of debt, and plus or minus gains or losses on acquisitions.

The following table presents a reconciliation of net income (loss), our most directly comparable GAAP financial performance measure for each of the periods presented, to EBITDA from continuing operations and Adjusted EBITDA from continuing operations.



	Three Months Ended September 30, 2019
	Specialty Petrochemicals		Specialty Waxes			Corporate			Consolidated
	(in thousands)
Net Income (Loss)	$	6,278	$	(2,071	)	$	(3,626	)	$	581
Loss from discontinued operations, net of tax	—		—			(1,002		)	(1,002		)
Income (Loss) from continuing operations	$	6,278	$	(2,071	)	$	(2,624	)	$	1,583
Interest	895		316			—			1,211
Taxes	803		—			(565		)	238
Depreciation and amortization	171		24			13			208
Depreciation and amortization in cost of sales	1,729		1,524			1			3,254
EBITDA from continuing operations	$	9,876	$	(207	)	$	(3,175	)	$	6,494
Stock-based compensation	—		—			415			415
Adjusted EBITDA from continuing operations	$	9,876	$	(207	)	$	(2,760	)	$	6,909



	Three Months Ended September 30, 2018
	Specialty Petrochemicals		Specialty Waxes			Corporate			Consolidated
	(in thousands)
Net Income (Loss)	$	2,504	$	(1,239	)	$	(2,874	)	$	(1,609	)
Loss from discontinued operations, net of tax	—		—			(893		)	(893		)
Income (Loss) from continuing operations	$	2,504	$	(1,239	)	$	(1,981	)	$	(716	)
Interest	659		265			—			924
Taxes	372		—			(608		)	(236		)
Depreciation and amortization	165		24			16			205
Depreciation and amortization in cost of sales	2,486		1,327			—			3,813
EBITDA from continuing operations	$	6,186	$	377		$	(2,573	)	$	3,990
Stock-based compensation	—		—			630			630
Loss on extinguishment of debt	—		—			315			315
Adjusted EBITDA from continuing operations	$	6,186	$	377		$	(1,628	)	$	4,935



Table of Contents
	24



	Nine Months Ended September 30, 2019
	Specialty Petrochemicals		Specialty Waxes			Corporate			Consolidated
	(in thousands)
Net Income (Loss)	$	17,086	$	(5,623	)	$	(6,727	)	$	4,736
Loss from discontinued operations, net of tax	—		—			(1,120		)	(1,120		)
Income (Loss) from continuing operations	$	17,086	$	(5,623	)	$	(5,607	)	$	5,856
Interest	3,143		967			1			4,111
Taxes	3,006		—			(1,594		)	1,412
Depreciation and amortization	512		72			45			629
Depreciation and amortization in cost of sales	7,387		4,223			1			11,611
EBITDA from continuing operations	$	31,134	$	(361	)	$	(7,154	)	$	23,619
Stock-based compensation	—		—			973			973
Adjusted EBITDA from continuing operations	$	31,134	$	(361	)	$	(6,181	)	$	24,592



	Nine Months Ended September 30, 2018
	Specialty Petrochemicals		Specialty Waxes			Corporate			Consolidated
	(in thousands)
Net Income (Loss)	$	10,402	$	(2,926	)	$	(4,518	)	$	2,958
Loss from discontinued operations, net of tax	—		—			(531		)	(531		)
Income (Loss) from continuing operations	$	10,402	$	(2,926	)	$	(3,987	)	$	3,489
Interest	1,892		802			(77		)	2,617
Taxes	2,387		—			(1,533		)	854
Depreciation and amortization	492		68			32			592
Depreciation and amortization in cost of sales	5,528		3,952			—			9,480
EBITDA from continuing operations	$	20,701	$	1,896		$	(5,565	)	$	17,032
Stock-based compensation	—		—			1,002			1,002
Loss on extinguishment of debt	—		—			315			315
Adjusted EBITDA from continuing operations	$	20,701	$	1,896		$	(4,248	)	$	18,349

Liquidity and Capital Resources

Working Capital

Our approximate working capital days are summarized as follows:



	September 30, 2019	December 31, 2018	September 30, 2018
Days sales outstanding in accounts receivable	35.5	34.4	38.1
Days sales outstanding in inventory	18.4	21.0	22.8
Days sales outstanding in accounts payable	14.1	24.2	17.0
Days of working capital	39.8	31.1	43.9

Our days sales outstanding in accounts receivable at September 30, 2019 was 35.5 days compared to 34.4 days at December 31, 2018, driven by slightly higher Specialty Petrochemicals sales volumes in the quarter. Our days sales outstanding in inventory decreased by approximately 2.6 days from December 31, 2018. Our days sales outstanding in accounts payable decreased due to payment for the Advanced Reformer unit catalyst replacement which was completed in December 2018, severance payments and payment for supplemental wax feed. Since days of working capital is calculated using the above three metrics, it increased for the aforementioned reasons discussed.



Table of Contents
	25

Cash increased $2.4 million during the nine months ended September 30, 2019, as compared to a decrease of $1.7 million for the nine months ended September 30, 2018.

The change in cash is summarized as follows:



	Nine Months Ended September 30,
	2019			2018
Net cash provided by (used in)	(thousands of dollars)
Operating activities	$	20,249		$	11,110
Investing activities	(4,254		)	(19,204		)
Financing activities	(13,573		)	6,358
Increase (Decrease) in cash	$	2,422		$	(1,736	)
Cash	$	9,157		$	1,292

Operating Activities

Cash provided by operating activities totaled $20.2 million for the first nine months of 2019, $9.1 million higher than the corresponding period in 2018. For the first nine months of 2019 net income increased by approximately $1.8 million as compared to the corresponding period in 2018. Major non-cash items affecting 2019 income in the first nine months of 2019 included increases in depreciation and amortization of $12.3 million, deferred taxes of $1.3 million and stock-based compensation of $0.9 million. Major non-cash items affecting 2018 income in the first nine months of 2018 included increases in deferred taxes of $1.1 million and depreciation and amortization of $10.0 million.

Additional factors leading to an increase in cash provided by operating activities included:


•	Trade receivables decreased approximately $1.6 million. This was due to a decrease in revenues in the third quarter 2019 of $6.7 million, or nearly 9.6%, as compared with the second quarter 2019. Revenues in the third quarter 2018 increased $5.3 million from the second quarter 2018.


•	Inventories decreased approximately $3.3 million driven by lower inventory in transit primarily due to lower sales to the Canadian oil sands and an overall decrease in value of inventory due to lower feedstock prices. Additionally, our Specialty Wax segment was constrained by disruptions of wax feed supply from a key supplier, resulting in increased sales of existing inventory.


•	In the first nine months of 2019, we did not have a change in taxes receivable. In the same period of 2018, we collected outstanding taxes receivable of $4.3 million related to prior periods and R&D credits.


•	Accounts payable and accrued liabilities decreased $6.0 million primarily due to payment for the Advanced Reformer unit catalyst replacement which was completed in December 2018, severance payments and payment for supplemental wax feed.

Investing Activities

Cash used in investing activities during the first nine months of 2019 was approximately $4.3 million, representing a decrease of approximately $15.0 million from the corresponding period of 2018. During the first nine months of 2019, the primary use of capital expenditures was for Advanced Reformer unit improvements and pipeline maintenance at SHR and equipment modifications at TC. This was offset by $1.3 million of proceeds received from AMAK for the repurchase of shares as discussed in Note 10 on our Annual Report on Form 10-K for the year ending December 31, 2018. In addition, $2.2 million related to the deposit was received in connection with the sale of our investment in AMAK discussed in Note 16. Our foreign tax liability resulting from AMAK's share repurchase program was $0.9 million. The cash to pay these taxes was withheld from the proceeds and paid directly by AMAK. As such, net cash received from AMAK was $0.4 million. During the first nine months of 2018, we had capital expenditures related to the hydrogenation/distillation unit and the Advanced Reformer unit along with various other facility improvements.



Table of Contents
	26

Financing Activities

Cash used in financing activities during the first nine months of 2019 was approximately $13.6 million versus cash provided by financing activities of $6.4 million during the corresponding period of 2018. During 2019, we made principal payments on our outstanding credit facilities of $15.3 million. We drew $2.0 million on our line of credit for working capital purposes during the first nine months of 2019. During 2018, we made principal payments on our acquisition loan of $3.5 million, our term debt of $0.7 million, and our line of credit facility of $8.1 million. We drew $18.2 million on our line of credit in the first nine months of 2018 to fund ongoing capital projects.

Subsequent to September 30, 2019, we made an optional principal payment of $5.0 million against the Revolving Facility, reducing the outstanding amount from $8.0 million to $3.0 million.

Anticipated Cash Needs

We believe that the Company is capable of supporting its operating requirements and capital expenditures through internally generated funds supplemented with borrowings under our ARC Agreement.

Results of Operations

Comparison of Three Months Ended September 30, 2019 and 2018

Specialty Petrochemicals Segment



	Three Months Ended September 30,
	2019			2018			Change			% Change
	(thousands of dollars)
Specialty Petrochemicals Product Sales	$	53,277		$	61,675		$	(8,398	)	(13.6	)%
Processing	1,208			2,056			(848		)	(41.2	)%
Gross Revenue	$	54,485		$	63,731		$	(9,246	)	(14.5	)%

Volume of Sales (gallons)
Specialty Petrochemicals Products	20,523			21,564			(1,041		)	(4.8	)%
Prime Product Sales	16,431			16,986			(555		)	(3.3	)%

Cost of Sales	$	44,206		$	57,156		(12,950		)	(22.7	)%
Gross Margin	18.9		%	10.3		%				8.6	%
Total Operating Expense*	17,248			18,673			(1,425		)	(7.6	)%
Natural Gas Expense*	1,000			1,265			(265		)	(20.9	)%
Operating Labor Costs*	3,619			4,837			(1,218		)	(25.2	)%
Transportation Costs*	6,997			7,126			(129		)	(1.8	)%
General & Administrative Expense	2,659			2,893			(234		)	(8.1	)%
Depreciation and Amortization**	1,900			2,651			(751		)	(28.3	)%
Capital Expenditures	2,163			2,562			(399		)	(15.6	)%

* Included in cost of sales

**Includes $1,729 and $2,486 for 2019 and 2018, respectively, which is included in operating expense

Gross Revenue

Gross Revenue for our Specialty Petrochemicals segment decreased during the third quarter 2019 from the third quarter 2018 by 14.5% primarily due to an 4.8% decrease in sales volume, a 9.2% decline in average selling price due mainly to lower feedstock costs and lower processing revenues.



Table of Contents
	27

Specialty Petrochemicals Product Sales

Specialty Petrochemicals product sales declined approximately 13.6% during the third quarter 2019 from the third quarter 2018 mainly due to lower product prices for prime products and by-products. Lower prices were primarily driven by lower feedstock costs. Prime product sales volume declined about 3.3% compared to the third quarter of 2018. Compared to the second quarter of 2019 prime product volume declined about 7.3% or about 1.3 million gallons primarily due to lower sales to the Canadian oil sands, and an unplanned outage at a major customer. The sales outlook to the Canadian oil sands continues to remain uncertain due to the government mandated crude production curtailments in Canada and the crude oil pricing environment. Also, we expect a decline in sales demand due to typical market seasonality in many of end-use markets.

By-product sales volumes in third quarter 2019 declined 10.6% from third quarter 2018. By-product sales volume increased 10.1% from second quarter 2019 due to an increase in feed to the Advanced Reformer unit which produces by-products. In the second quarter 2019 feed to the Advanced Reformer was diverted to maximize prime product production to meet certain customer needs . It should be noted that by-products are produced as a result of prime product production and their margins are significantly lower than margins for our prime products. Foreign sales volume increased to 22.4% of total Specialty Petrochemicals volume in the third quarter of 2019, from 21.5% in the third quarter 2018. Foreign sales volume includes sales to the Canadian oil sands.

Processing

Processing revenues decreased approximately $0.8 million or 41.2% in the third quarter 2019 from the third quarter 2018 primarily due to the termination of a customer contract in the fourth quarter 2018.

Cost of Sales

We use natural gasoline as feedstock, which is the heavier liquid remaining after ethane, propane and butanes are removed from liquids produced by natural gas wells. The material is a commodity product in the oil/petrochemical markets and generally is readily available. The price of natural gasoline is highly correlated with the price of crude oil. Our Advanced Reformer unit upgrades the by-product stream produced as a result of prime product production. This upgrade allows us to sell our by-products at higher prices than would be possible without the Advanced Reformer unit.

Cost of Sales declined 22.7% during the third quarter 2019 from the third quarter 2018. The decline of approximately $13 million in cost of sales was largely due to lower feedstock costs. Benchmark Mount Belvieu natural gasoline feedstock price declined 31% from $1.54 per gallon in the third quarter of 2018 to $1.06 per gallon in the third quarter of 2019. Compared to the second quarter of 2019 benchmark Mount Belvieu natural gasoline feedstock price for the third quarter 2019 declined 12%. Natural gasoline feedstock pricing historically has been volatile. We sell our prime products under both formula-based pricing, where feedstock costs are passed through to the customer, and spot or non-formula-based pricing, which do not have pricing formulas tied to feedstock costs. Formula-based pricing is used to sell the majority of our prime products.

The gross margin percentage for the Specialty Petrochemicals Segment increased from 10.3% in the third quarter of 2018 to 18.9% in the third quarter of 2019 driven by lower feedstock costs, lower operating expenses and improved margins over feed for by-products.

Total Operating Expense

Total Operating Expense decreased $1.4 million, or 7.6%, during the third quarter 2019 from 2018. There were several key drivers for the decrease, including lower labor costs, lower natural gas costs and lower transportation costs. Labor costs were lower mainly due to the cost reduction program implemented at SHR in December 2018.

Capital Expenditures

Capital expenditures in the third quarter 2019 were approximately $2.2 million compared to $2.6 million in the third quarter of 2018. Following the completion of the Advanced Reformer unit in the second quarter of 2018, capital expenditures mainly include routine plant maintenance and environmental, health and safety (EH&S) projects.



Table of Contents
	28

Specialty Waxes Segment



	Three Months Ended September 30,
	2019			2018			Change			% Change
	(thousands of dollars)
Product Sales	$	5,834		$	6,938		$	(1,104	)	(15.9	)%
Processing	2,396			2,799			(403		)	(14.4	)%
Gross Revenue	$	8,230		$	9,737		$	(1,507	)	(15.5	)%

Volume of specialty wax sales (thousand pounds)	8,649			9,055			(406		)	(4.5	)%

Cost of Sales	$	8,879		$	9,470		$	(591	)	(6.2	)%
Gross Margin (Loss)	(7.9		)%	2.7		%				(10.6	)%
General & Administrative Expense	1,071			1,180			(109		)	(9.2	)%
Depreciation and Amortization*	1,548			1,351			197			14.6	%
Capital Expenditures	$	361		$	1,094		$	(733	)	(67.0	)%

*Includes $1,524 and $1,327 for 2019 and 2018, respectively, which is included in cost of sales

Product Sales

For the Specialty Wax Segment Product sales revenue decreased 15.9% during the third quarter 2019 from the third quarter 2018 as specialty wax sales volume declined 4.5%. Wax sales were constrained by disruptions of wax feed supply from a key suppliers as they experienced their own operating difficulties. Our wax feed is based on certain by-products produced as a result of polyethylene production at major polyethylene producers' facilities on the US Gulf Coast. Customer demand in the third quarter was strong and our sales remained limited by wax feed supply.

Processing

Processing revenues declined 14.4% or about $0.4 million during the third quarter 2019 from the third quarter 2018. The decrease was due to lower revenues from the hydrogenation/distillation unit as we work to improve the unit's reliability and lower demand from certain custom processing customers.

Cost of Sales

Cost of Sales were lower in the third quarter 2019 from the third quarter 2018 due to lower wax sales.

Depreciation

Depreciation for the third quarter 2019 was $1.49 million relatively flat from third quarter 2018.

Capital Expenditures

Capital Expenditures were approximately $0.4 million in the third quarter 2019 compared with $1.1 million in the third quarter of 2018.

Corporate Segment



	Three Months Ended September 30,
	2019		2018		Change		% Change
	(thousands of dollars)
General & Administrative Expense	$	2,670	$	2,252	$	418	18.6	%

General corporate expenses increased during the third quarter 2019 from the third quarter 2018. The increase is primarily attributable to an increase in executive compensation accrual.



Table of Contents
	29

Investment in AMAK - Discontinued Operations



	Three Months Ended September 30,
	2019			2018			Change			% Change
	(thousands of dollars)
Equity in (losses) earnings of AMAK	$	(1,268	)	$	(1,130	)	$	(138	)	12.2	%

Equity in earnings (losses) of AMAK decreased during the third quarter 2019 from the third quarter 2018. The equity in earnings (losses) were impacted by increased selling, general and administrative expenses.

AMAK Summarized Income Statement



	Three Months Ended September 30,
	2019			2018
	(thousands of dollars)
Sales	$	19,643		$	19,877
Cost of sales	19,072			20,350
Gross profit	571			(473		)
Selling, general, and administrative	3,557			2,736
Operating (loss) income	(2,986		)	(3,209		)
Other (expense) income	43			35
Finance and interest expense	(456		)	(416		)
Loss before Zakat and income taxes	(3,399		)	(3,590		)
Zakat and income taxes	444			800
Net Loss	$	(3,843	)	$	(4,390	)

Finance and interest expense	456			416
Depreciation and amortization	8,534			8,899
Zakat and income taxes	444			800
EBITDA	$	5,591		$	5,725

AMAK continued to make progress in throughput rates, concentrate quality and recoveries. Approximately 18,000 dry metric tons (dmt) of copper and zinc concentrate were shipped in the third quarter 2019 as compared to 17,000 dmt of copper and zinc concentrate in the third quarter 2018. Third quarter EBITDA was approximately $5.6 million, relatively flat compared to the third quarter 2018.



Table of Contents
	30

Comparison of Nine Months Ended September 30, 2019 and 2018

Specialty Petrochemicals Segment



	Nine Months Ended September 30,
	2019			2018			Change			% Change
	(thousands of dollars)
Specialty Petrochemicals Product Sales	167,351			178,094			$	(10,743	)	(6.0	)%
Processing	4,117			5,769			(1,652		)	(28.6	)%
Gross Revenue	$	171,468		$	183,863		$	(12,395	)	(6.7	)%

Volume of Sales (gallons)
Specialty Petrochemicals Products	64,438			64,586			(148		)	(0.2	)%
Prime Product Sales	51,801			50,729			1,072			2.1	%

Cost of Sales	140,121			160,543			(20,422		)	(12.7	)%
Gross Margin	18.3		%	12.7		%				5.6	%
Total Operating Expense*	53,983			51,597			2,386			4.6	%
Natural Gas Expense*	3,636			3,841			(205		)	(5.3	)%
Operating Labor Costs*	10,918			13,351			(2,433		)	(18.2	)%
Transportation Costs*	21,405			21,528			(123		)	(0.6	)%
General & Administrative Expense	7,950			8,193			(243		)	(3.0	)%
Depreciation and Amortization**	7,899			6,020			1,879			31.2	%
Capital Expenditures	5,002			16,374			(11,372		)	(69.5	)%

* Included in cost of sales

**Includes $7,387 and $5,528 for 2019 and 2018, respectively, which is included in operating expense

Gross Revenue

Gross Revenue for our Specialty Petrochemicals segment decreased during the first nine months of 2019 from the first nine months of 2018 by 6.7% primarily due to a decrease in the average selling price of Specialty Petrochemicals products of 5.8% and lower processing revenue of $1.7 million.

Specialty Petrochemicals Product Sales

Revenues from Specialty Petrochemicals product sales decreased 6.0% during the first nine months of 2019 from the first nine months of 2018. This was primarily due to a 5.8% decrease in average selling price as a result of lower feedstock pricing. Prime product sales volumes were up 2.1% or approximately 1.1 million gallons for the first nine months of 2019 compared to the same period in 2018. The increase in sales volume was mainly due to a large sale for supplier qualification at an oil sands customer. Average selling prices decreased as prices for both prime products and by-products declined in concert with lower feedstock costs. By-product margins increased for the first nine months of 2019 compared to first nine months of 2018 primarily as a result of steady and reliable operation of the Advanced Reformer unit which upgrades the by-product stream to higher value chemical products that are sold at higher prices than would be possible without the Advanced Reformer unit. By-products are produced as a result of prime product production and their margins are significantly lower than margins for our prime products. Foreign sales volume increased to 24.1% of total Specialty Petrochemicals volume from 23.0% in the first nine months of 2018.

Processing

Processing revenues decreased $1.7 million or 28.6% in the first nine months of 2019 from the first nine months of 2018 due to the termination of a customer contract in the fourth quarter 2018.



Table of Contents
	31

Cost of Sales

Cost of Sales declined 12.7% during the first nine months of 2019 from the first nine months of 2018 due to the decrease in feedstock cost. For the first nine months of 2019 compared with the same period in 2018, benchmark Mount Belvieu natural gasoline feedstock price declined 24% from approximately $1.49 per gallon to $1.13 per gallon. We sell our prime products under both formula-based pricing where feedstock costs are passed through to the customer and spot or non-formula based pricing which do not have pricing formulas tied to feedstock costs. Formula-based pricing is used to sell the majority of our prime products.

The gross margin percentage for the Specialty Petrochemicals Segment increased from 12.7% in the first nine months of 2018 to 18.3% in the first nine months of 2019 driven by lower feedstock costs resulting in better product margins, significantly higher by-product margins primarily due to more reliable operation of the Advanced Reformer unit and lower labor costs as a result of the cost reduction program implemented at SHR in December 2018.

Total Operating Expense

Total Operating Expense increased 4.6% during the first nine months of 2019 from 2018. Lower labor costs and lower other operating expenses were more than offset by $1.9 million increase in depreciation and amortization related to the Advanced Reformer unit which came on line in the third quarter of 2018.

Capital Expenditures

Capital Expenditures in the first nine months of 2019 were approximately $5.0 million compared to $16.4 million in the first nine months of 2018. The bulk of 2019 capital expenditures were related to modifications and improvements to the Advanced Reformer unit and natural gasoline feedstock pipeline maintenance work.

Specialty Waxes Segment



	Nine Months Ended September 30,
	2019			2018			Change			% Change
	(thousands of dollars)
Product Sales	$	18,582		$	20,755		$	(2,173	)	(10.5	)%
Processing	7,191			8,863			(1,672		)	(18.9	)%
Gross Revenue	$	25,773		$	29,618		$	(3,845	)	(13.0	)%

Volume of specialty wax sales (thousand pounds)	26,486			29,140			(2,654		)	(9.1	)%

Cost of Sales	$	26,852		$	27,814		$	(962	)	(3.5	)%
Gross Margin (Loss)	(4.2		)%	6.1		%				(10.3	)%
General & Administrative Expense	3,423			3,787			(364		)	(9.6	)%
Depreciation and Amortization*	4,295			4,020			275			6.8	%
Capital Expenditures	$	1,296		$	2,716		$	(1,420	)	(52.3	)%

*Includes $4,223 and $3,952 for 2019 and 2018, respectively, which is included in cost of sales

Product Sales

Product sales revenue decreased 10.5% during the first nine months of 2019 from the first nine months of 2018 as specialty wax sales volume declined 9.1%. Planned maintenance turnaround at our Pasadena facility in the first quarter of 2019, along with outages at multiple wax feed suppliers, constrained specialty wax production and thereby sales. In addition, in 2018 sales benefited from one-time sales of off-spec product that did not meet customer specifications. Customer demand during the first nine months of 2019 was strong and our sales remained limited by wax feed supply.



Table of Contents
	32

Processing

Processing revenues declined approximately $1.7 million during the first nine months of 2019 from the first nine months of 2018. The decrease was due to lower revenues from the hydrogenation/distillation unit as we work to improve the unit's reliability and lower demand from certain custom processing customers.

Cost of Sales

Cost of Sales decreased 3.5% or approximately $1.0 million during the first nine months of 2019 from the first nine months of 2018 as a result of lower wax sales and lower operating expenses.

Depreciation

Depreciation increased 6.8% during the first nine months of 2019 from the first nine months of 2018.

Capital Expenditures

Capital Expenditures were approximately $1.3 million in the first nine months of 2019 compared with $2.7 million in the first nine months of 2018.

Corporate Segment



	Nine Months Ended September 30,
	2019		2018		Change		% Change
	(thousands of dollars)
General & Administrative Expense	$	7,159	$	5,234	$	1,925	36.8	%

General corporate expenses increased approximately $1.9 million during the first nine months of 2019 from the first nine months of 2018. The increase is primarily attributable to the second quarter 2018 cancellation and reversal of stock compensation expense and other post-retirement benefits totaling approximately $1.5 million previously awarded to Mr. Hatem El Khalidi.

Investment in AMAK - Discontinued Operations



	Nine Months Ended September 30,
	2019		2018		Change		% Change
	(thousands of dollars)
Equity in (losses) earnings of AMAK	(1,418	)	(672	)	(746	)	111.0	%

Equity in earnings (losses) of AMAK decreased during the first nine months of 2019 from the first nine months of 2018. The equity in earnings (losses) were impacted by increased selling, general and administrative expenses.



Table of Contents
	33

AMAK Summarized Income Statement



	Nine Months Ended September 30, 2019
	2019			2018
	(thousands of dollars)
Sales	$	60,873		$	53,458
Cost of sales	55,804			49,411
Gross profit	5,069			4,047
Selling, general, and administrative	9,102			7,151
Operating income (loss)	(4,033		)	(3,104		)
Other income	396			70
Finance and interest expense	(1,349		)	(1,201		)
Loss before Zakat and income taxes	(4,986		)	(4,235		)
Zakat and income taxes	1,332			800
Net Loss	$	(6,318	)	$	(5,035	)

Finance and interest expense	1,349			1,201
Depreciation and amortization	23,604			24,881
Zakat and income taxes	1,332			800
EBITDA	$	19,967		$	21,847

AMAK continued to make progress in throughput rates, concentrate quality and recoveries. Approximately 49,000 dry metric tons (dmt) of copper and zinc concentrate were shipped in the first nine months of 2019 as compared to 42,000 dmt of copper and zinc concentrate in the first nine months of 2018. EBITDA shows a decline of approximately $1.9 million compared to the first nine months of 2018 primarily due to increased cost of sales resulting from a change in inventory valuation methodology and one-time non-recurring expenses.

Contractual Obligations

Our contractual obligations are summarized in Part II, Item 7. "Management's Discussion and Analysis of Financial Condition and Results of Operations," in our Annual Report on Form 10-K for the year ended December 31, 2018. See Note 10 for changes to our debt maturity schedule. There have been no other material changes to the contractual obligation amounts disclosed in our Annual Report on Form 10-K for the year ended December 31, 2018.

Critical Accounting Policies and Estimates

Critical accounting policies are more fully described in Note 2, “Summary of Significant Accounting Policies” to the consolidated financial statements set forth in our Annual Report on Form 10-K for the year ended December 31, 2018. The preparation of consolidated financial statements in accordance with generally accepted accounting principles requires management to make estimates, assumptions and judgments that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the consolidated financial statements, and the reported amounts of revenue and expenses during the period reported. By their nature, these estimates, assumptions and judgments are subject to an inherent degree of uncertainty. We base our estimates, assumptions and judgments on historical experience, market trends and other factors that are believed to be reasonable under the circumstances. Estimates, assumptions and judgments are reviewed on an ongoing basis and the effects of revisions are reflected in the consolidated financial statements in the period they are determined to be necessary. Actual results may differ from these estimates under different assumptions or conditions. Our critical accounting policies and estimates have been discussed with the Audit Committee of the Board of Directors and discussed in our Annual Report on Form 10-K for the year ended December 31, 2018. For the nine months ended September 30, 2019, there were no significant changes to these policies except for the policies related to the accounting for



Table of Contents
	34

leases as a result of the adoption of ASU 2016-02, Leases, as of January 1, 2019 as described in Note 1 – General and Note 8 – Leases in the accompanying condensed consolidated financial statements.

Recent and New Accounting Standards

See Note 1 and 2 to the Consolidated Financial Statements for a summary of recent accounting guidance.

Off Balance Sheet Arrangements

Off balance sheet arrangements as defined by the SEC means any transaction, agreement or other contractual arrangement to which an entity unconsolidated with the registrant is a party, under which the registrant has (i) obligations under certain guarantees or contracts, (ii) retained or contingent interest in assets transferred to an unconsolidated entity or similar arrangements, (iii) obligations under certain derivative arrangements, and (iv) obligations arising out of a material variable interest in an unconsolidated entity. Our guarantee for AMAK's debt is considered an off balance sheet arrangement. Please see further discussion in Notes 16 and 19 to the Condensed Consolidated Financial Statements.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.

For quantitative and qualitative disclosure about market risk, see Part II, Item 7A, Quantitative and Qualitative Disclosures about Market Risk in our Annual Report on Form 10–K for the year ended December 31, 2018. There have been no material changes in the Company's exposure to market risk from the disclosure included in such report.

ITEM 4. CONTROLS AND PROCEDURES.

(a)

Evaluation of disclosure controls and procedures. Our Chief Executive Officer and Chief Financial Officer, with the participation of management, have evaluated the effectiveness of our "disclosure controls and procedures" (as defined in Rules 13a-15(e) and 15(d)-15(e) under the Securities Exchange Act of 1934) and determined that our disclosure controls and procedures were effective as of the end of the period covered by this report.


(b)	Changes in internal control. There were no significant changes in our internal control over financial reporting that occurred during the three months ended September 30, 2019, that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.



Table of Contents
	35

PART II. OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.

The Company is periodically named in legal actions arising from normal business activities. The Company evaluates the merits of these actions and, if it determines that an unfavorable outcome is probable and can be reasonably estimated, the Company will establish the necessary reserves. We are not currently involved in legal proceedings that could reasonably be expected to have a material adverse effect on our business, prospects, financial condition or results of operations. We may become involved in material legal proceedings in the future.

ITEM 1A. RISK FACTORS.

Readers of this Quarterly Report on Form 10–Q should carefully consider the risks described in the Company's other reports and filings filed with or furnished to the SEC, including the Company's prior and subsequent reports on Forms 10–K, 10–Q and 8–K, in connection with any evaluation of the Company's financial position, results of operations and cash flows.

The risks and uncertainties in the Company's most recent Annual Report on Form 10–K are not the only risks that the Company faces. Additional risks and uncertainties not presently known or those that are currently deemed immaterial may also affect the Company's operations. Any of the risks, uncertainties, events or circumstances described therein could cause the Company's future financial condition, results of operations or cash flows to be adversely affected. There have been no material changes from the risk factors previously disclosed in the Company's Annual Report on Form 10-K for the year ended December 31, 2018, except as noted below.

Consummation of the sale of the Company's equity interest in AMAK is subject to a number of closing conditions, including receipt certain governmental approvals, that may not be satisfied, and the closing of the sale may be delayed or the sale may not be completed as contemplated, or at all.

Although we have entered into the Purchase Agreement with respect to the sale of the Company's equity interest in AMAK to the Purchasers, we cannot guarantee when, or whether the sale will be completed. The closing of the sale is subject to closing conditions, including the receipt of certain governmental approvals from the Saudi Arabian Deputy Ministry for Mineral Resources and the SIDF (with respect to release of the Company's limited guarantee of the Loan (as described in Note 18)). If the closing conditions are not satisfied or waived (to the extent any such condition may be waived), in either a timely manner or at all, the closing of the sale may be delayed or may not be completed as contemplated, or at all, which could cause us not to realize some or all of the anticipated benefits of the transaction. In addition, the market price of the Company's common stock may reflect an assumption that the pending sale will occur and on a timely basis, and the failure to do so may result in a decline in the market price of the Company's common stock.



Table of Contents
	36

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.

Unregistered Sales of Equity Securities

In connection with certain amendments to his Employment Contract, Peter M. Loggenberg, our Chief Sustainability Officer, was granted 4,400 restricted shares of our common stock on February 21, 2019. The restricted shares were issued pursuant to an exemption from registration under Section 4(a)(2) of the Securities Act of 1933, as amended, and vest in equal increments over a three year period.

ITEM 6. EXHIBITS.

The following documents are filed or incorporated by reference as exhibits to this Report. Exhibits marked with an asterisk (*) are filed herewith and exhibits marked with a double asterisk (**) are furnished herewith.



Exhibit Number	Description
2.1*	Share Sale and Purchase Agreement, dated as of September 22, 2019, among Trecora Resources, Al Masane Al Kobra Mining Company and the other purchasers named therein
31.1*	Certification of Chief Executive Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934
31.2*	Certification of Chief Financial Officer pursuant to Rule 13a-14(a) of the Securities Exchange Act of 1934
32.1**	Certification of Chief Executive Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
32.2**	Certification of Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
101.INS*	XBRL Instance Document
101.SCH*	XBRL Taxonomy Schema Document
101.CAL*	XBRL Taxonomy Calculation Linkbase Document
101.LAB*	XBRL Taxonomy Label Linkbase Document
101.PRE*	XBRL Taxonomy Extension Presentation Linkbase Document
101.DEF*	XBRL Taxonomy Extension Definition Linkbase Document



Table of Contents
	37

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.



	TRECORA RESOURCES

Dated: November 8, 2019	By:	/s/ Sami Ahmad
		Sami Ahmad
		Principal Financial Officer and Duly Authorized Officer



Table of Contents
	38